Castells E, Ferran V, Octavio de Toledo M C, Calbet J M, Benito M, Fontanillas C, Granados J, Obi C L, Saura E
Service of Cardiac Surgery, Hospital de Bellvitge Princeps d'Espanya, Barcelona.
J Cardiovasc Surg (Torino). 1993 Feb;34(1):49-53.
Long-term results of the surgical treatment of cardiac myxomas are not completely understood due to its recurrence. We review our experience in 27 operated cases with a follow-up to 22 years (mean 6.5 years), in order to throw light on results and review the problem of recurrence. One patient had a previous recurrent myxoma. At surgery we resect all the tumors and their attachment bases. We prefer a biatrial approach, ample resection and exploration of all cardiac chambers. Hospital mortality was 3.7% (1 case of associated aortic valve replacement) and late mortality 7%. Long-term results were satisfactory, without recurrences. The postoperative life expectancy of these patients seems similar to that of the normal population, except in cases of recurrence or associated valve replacement. Recurrence is very low (4.7% in 526 cases reported in the literature), except in the case of young patients and recurrent, familial, multiple or complex myxomas. The multigrowth potential of the tumor seems more important than an inadequate surgical resection.
由于心脏黏液瘤会复发，其外科治疗的长期结果尚未完全明了。我们回顾了27例手术病例的经验，随访时间长达22年（平均6.5年），以便阐明治疗结果并审视复发问题。1例患者曾有黏液瘤复发史。手术时，我们切除了所有肿瘤及其附着基底。我们更倾向于采用双心房入路，充分切除并探查所有心腔。住院死亡率为3.7%（1例合并主动脉瓣置换），晚期死亡率为7%。长期结果令人满意，无复发情况。这些患者的术后预期寿命似乎与正常人群相似，但复发或合并瓣膜置换的病例除外。复发率很低（文献报道的526例中为4.7%），年轻患者以及复发、家族性、多发性或复杂性黏液瘤患者除外。肿瘤的多生长潜能似乎比手术切除不充分更为重要。
